Replies to post #643211 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

You mean the 5 year survival rate is 206% of what it was before.

[supersteve13]

Optune was approved with zero OS benefit, despite OS being the primary endpoint. (EF11 trial). That trial failed by definition, whereas the Dcvax phase 3 met both of the prespecified primary endpoints in the SAP. :)

Keep these facts in mind when Ex repeats his lies. :)